tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Enfusion narrows FY24 EPS view to $202M-205M, consensus $204.8M

Sees FY24 adusted EBITDA $41M-45M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1